People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Halscion Inc | — | Biotechnology | Series A | $13.8M | $155.4M | 2009 |
Steven B. Waite at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven B. Waite on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anthony Lando | 1 | 6 |
| James Garvey | 1 | 6 |
| Gerard Van Hamel Platerink | 1 | 6 |
| Charles Warden | 1 | 5 |
| Ron Yamamoto | 1 | 2 |
| Samuel B. Wu | 1 | 2 |
| Gerard B. Van Hamel Platerink | 1 | 2 |
| Kathleen Beauchamp | 1 | 2 |
| Anthony B. Lando | 1 | 1 |
| Charles B. Warden | 1 | 1 |
| Jonathan Wyler | 1 | 1 |
| Ronald Yamamoto | 1 | 1 |
| Thomas B. Weldon | 1 | 1 |
| Robert Leslie | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.